Кузин М. И., Гехт Б. М. Миастения

Вид материалаДокументы
Подобный материал:
1   2   3
998. – P.343–350.

ссылка скрыта Frequency of myasthenic crisis in relation to thymectomy in generalized myasthenia gravis: a 17-year experience // B.M.C. Neurol. – 2004. – V.11. – P.4-12.

Somnier F.E. Clinical implementation of anti-acetylcholine receptor antibodies // J. Neurol. Neurosurg. Psychiat. – 1993. – V. 56. – P.496-504.

Somnier F.E. Myasthenia gravis // J. Dan. Med. Bull. - 1996. - V.43. - №1. - P.1-10.

Somnier F.E., Engel A.G. The occurrence of anti-titin antibodies and thymomas: a population survery of MG 1970-1999 // Neurology. - 2002. – V.9. - P.92-98.

Somnier F.E., Skeie G.O., Aarli J.A., Trojaborg W. EMG evidence of myopathy and the occurrence of titin autoantibodies in patient with myasthenia gravis // Europ. J. Neurol. - 1999. - №6. - P.555-563.

Somnier F.E., Trojaborg W. Neurophysiological evaluation in myasthenia gravis. A comprehensive study of a complete patient population // Electroencephalogr. Clin. Neurophysiol. - 1993. - V.89. - №2. - P.73-87.

ссылка скрыта Immunological studies in thymectomized and non-thymectomized patients with myasthenia gravis // J. Clin. Lab. Immunol. – 1978. – V.3. – P.169-178.

Stalberg E. Clinical electrophysiology in myasthenia gravis // J. Neurol., Neurosurg., Psychiat. - 1980. - V.43. - P.622-633.

ссылка скрыта Electrophysiological cross section of the motor unit // J. Neurol., Neurosurg., Psychiat. – 1980. – V.43. – P.469-474.

Stalberg E., Fawsett P.R Macro EMG in healthy subjects of different ages // J. Neurol., Neurosurg., Psychiat. – 1982. - V.45. - P.870-878.

Sprent J. The thymus and T-cell tolerance // Ann. N.Y. Acad. Sci. - 1993. - V.681. - P.5-15.

ссылка скрыта T-cell selection in the thymus // Princess Takamatsu Symp. – 1988. – V.19. – P.127-136.

Strauss A.J., Kemp P.G. Serum autoantibodies in myasthenia gravis: relective affinity for J-bands of striated muscle as a guede to identification of antigen (S) // J. Immunol. - 1967. - V.99. - P.945-953.

Sudhof T.C., Rizo J. Synaptotagmins: C2-domain proteins that regulate membrane traffic // Neuron. – 1996. –V.17. - P.379-388.

Sund K.K., Skeie G.O., Gilhus N.E., Aarli J., Varhaug J.E. Diagnosis of thymoma and thymic atrophy in patients with myasthenia gravis // Tidsskr. Nor. Laegeforen. - 1997. - V.117. - P.4212-4214.

ссылка скрыта Novel autoantibodies to a form of myasthenia gravis // J. Neuroimmunol. – 2005. – V.170. - №1-2. – P.141-149.

Szobor A. Myasthenia gravis: a quantitative evaluation system. Disability status scale (DDS) applide for myasthenia gravis // Europ. Neurol. - 1976. - V.14. - P.439-446.

Takamori M., Homada T., Komai K. Synaptotagmin can cause an immune-mediated model of Lambert-Eaton myasthenic syndrome in rats // Ann. Neurol. - 1994. - V.35. - P.74-80.

Takamori M., Takahashi M., Yasukawa Y. et al. Antibodies to recombinant synaptotagmin and calcium channel subtypes in Lambert-Eaton myasthenic syndrome // J. Neuro. Sci. - 1995. - V.133. – P.95-101.

Tim R.W., Massey J.M., Sanders D.B. Lambert-Eaton syndrome (LEMS): Clinical and electrodiagnostic features and response to therapy in 59 patients // Ann. N.Y. Acad. Sci. – 1998. – V.841. – P. 823-826.

Tim R.W., Sanders D.B. Repetitive nerve stimulation studies in the Lambert-Eaton myasthenic syndrome // Muscle & Nerve. - 1994. - V.17. - P.995-1001.

Tindall R.S.A. Humoral immunity in myasthenia gravis: biochemical characterization of acquired acetylcholine receptor antibodies and clinical correlations // Ann. Neurology. - 1981. - V.10. - P.437-447.

Trinick J. Elastic filaments and giant proteins in muscle // Current Opinion in Cell Biology. - 1991. – V.3. - P.112-119.

Tseng Y.L., Chang J.M., Shu I.L., Wu M.H. Myasthenia gravis developed 30 months after resection of recurrent thymoma // Eur. J. Cardiothorac. Surg. – 2006. – V.29. – P. 268-269.

Twomey J.J., Lewis V.M., Patten B.M., Goldstein G., Good R.A. Myasthenia gravis, thymectomy and serum thymic hormone activity // Am. J. Med. – 1979. – V.66. – P. 639-643.

Tzartos S.J., Langeberg L., Hochschwender S., Lindstrom J. Demonstration of a main immunogenic region on acetylcholine receptors from human muscle using monoclonal antibodies to human receptors // FEBS Letters. – 1983. – V.158. - P.116-118.

ссылка скрыта Receptor tyrosine kinase specific for the skeletal muscle lineage: expression in embryonic muscle, at the neuromuscular junction, and after injury // Neuron. 1995. – V.15. - №3. – P.573-584.

Verley J.M., Hollmann K.H., Thymoma. A comparative study of clinical stages, histologic features and survival in 200 cases // Cancer. – 1985. – V.55. - №5. – P.1074-1086.

Vernino S., Auger R.G., Emslie-Smith A.M., Harper C.V., Lennon V.A. Myasthenia, thymoma, presynaptic antibodies and a continuum of neuromuscular hyperexcitability // Neurol. - 1999. - V.53. - №.6. - P.1233-1239.

Vernino S., Lennon V.A. Autoantibody profiles and neurological correlations of thymoma // Clin. Cancer Res. - 2004. - V.10. - №21. - P.7270-7275.

Vernino S., Low P.A., Fealey R.D., Stewart J.D., Farrugia G., Lennon V.A. Autoantibodies to Ganglionic Acetylcholine Receptors in Autoimmune Autonomic Neuropathies // N. Engl. J. Med. - 2000. – V.343. – P.847-855.

Vieira M.L., Cailatt-Zucman S., Gaidos P. Identification by genomic of non DR3 HLA class 11 gens associated with myasthenia gravis // J. Neuroimmunol. - 1993. - V.47. - P.115-122.

ссылка скрыта Neuroimmunology of myasthenia gravis // Brain Behav. Immun. – 1988. - V2. – P.346-351.

Vincent A. Immunology of the neuromuscular junction: myasthenia gravis and the Lamert-Eaton myasthenic syndrome // Annual Convenntional meeting of Russian Society for Multiple Sklerosis / Frontiers in Science and Disease Management. St. Peterurg. - 1997. - P.74-75.

Vincent A., Beeson D., Lang B. Molecular targets for autoimmune and genetic disorders of neuromuscular transmission // Eur. J. Biochem. - 2000. - V.267. - P.6717-6728.

Vincent A., Dalton P., Clover L., Palace J., Lang B. Antibodies to neuronal targets in neurological and psychiatric diseases // Ann. N.Y. Acad. Sci. 2003. – V.992. – P.48-55.

ссылка скрыта Seronegative myasthenia gravis // Semin. Neurol. – 2004. – V.24. - №1. – P.125-133.

ссылка скрыта Is "seronegative" MG explained by autoantibodies to MuSK // Neurol. – 2005. – V.64. - №2. – P.399.

Vincent A., Scadding G.K., Clarke C., Newson-Davis J. In vitro synthesis of antiacetylcholine receptor antibodies by thymic lymphocytes in myasthenia gravis // Lanset. - 1978. - V.1. - P.305-307.

Vincent A., Newson-Davis J. Antiacetylcholine receptor antibodies // J. Neurol., Neurosurg., Psychiat. - 1980. - V.43. - P.590-600.

Voltz R., Albrich W., Nagele A., Schumm F., Wick M., Freiburg A., Gautel M., Thaler H., Aarli J., Kirchner T., Hohlfeld R. // Paraneoplastic myasthenia gravis: detection of anti-MGT30 (titin) antibodies predicts thymic epithelial tumor // Neurol. - 1997. - V. 49. - P.1454-1457.

Voltz R., Albrich W., Hohlfeld R., Nagel D., Wick M. et al. Anti-titin antibodies are not associated with a specific thymoma histology // J. Neurol. Neurosurg. Psychiat. – 2003. – V.74. – P. 282.

ссылка скрыта Cytoskeletal matrix in striated muscle: the role of titin, nebulin and intermediate filaments // Adv. Exp. Med. Biol. – 1984. – V.170. – P.285-305.

ссылка скрыта Regulation of skeletal muscle stiffness and elasticity by titin isoforms: a test of the segmental extension model of resting tension // Proc. Natl. Acad. Sci. U S A. – 1991. – V.88. – P.7101-7105.

ссылка скрыта Viscoelasticity of the sarcomere matrix of skeletal muscles. The titin-myosin composite filament is a dual-stage molecular spring // Biophys. J. – 1993. – V.64. - №4. – P.1161-1177.

ссылка скрыта Th1 epitope repertoire on the alpha subunit of human muscle acetylcholine receptor in myasthenia gravis // Neurol. – 1997. – V.48. - №6. – P. 1643-1653.

Warlow R.S., Garlepp M., Teeney D. Antiacetylcholine receptor and antimuscular antibodies in myasthenia gravis. Correlation with MZA, sex and Ig M // Exp. Clin. Immunogen. - 1985. - V.2. - №3. - P.158-160.

ссылка скрыта The thymus in myasthenia gravis // Ann. N. Y. Acad. Sci. – 1993. – V.681. – P.47-55.

ссылка скрыта Autoimmunity and neurological disease: antibody modulation of synaptic transmission // Ann. Rev. Neurosci. – 1999. – V.22. – P.175-195.

Willcox N. Myasthenia gravis // Curr. Opin. Immunol. – 1993. - V.5. - P. 910–917.

Willcox N., Schluep M., Ritter M. A., Schuurman H. J., Newsom-Davis J., Christenson B. Myasthenic and nonmyasthenic thymoma: an expansion of a minor cortical epithelial cell subser? // Am. J. Pathol. – 1987. – V.127. - P. 447–460.

Wirtz P.W., Lang B., Graus F. et al. P/Q-type calcium channel antibodies, Lambert-Eaton myasthenic syndrome and survival in small cell lung cancer // J. Neuroimmunol. – 2005. – V.5. – P.16-24.

Wray D., Porter V. Calcium channel types at the neuromuscular junction // Ann. N.Y. Acad. Sci. - 1994. - V.681. - P.356-367.

Yeh J.H., Chen W.H., Chiu H.C., Vincent A. Low frequency of MuSK antibody in generalized seronegative myasthenia gravis among Chinese // Neurol. – 2004. – V.62. - №11. – P.2131-2132.

ссылка скрыта Autoreactive T cell responses and cytokine patterns reflect resistance to experimental autoimmune myasthenia gravis in Wistar Furth rats // Eur. J. Immunol. – 1996. – V.26. - №11. – P.2552-2558.

ссылка скрыта Cytokines and the pathogenesis of myasthenia gravis // Muscle & Nerve. - 1997. – V.20. - №5. – P.543-551.

Zhang W., Lie J.L., Meager A., Newsom-Davis J., Willcox N. Autoantibodies to IL-12 in myasthenia gravis patients with thymoma; effects on the IFN-gamma responses of healthy CD4+ T cells // J. Neuroimmunol. - 2003. - V.139. - №1-2. – P.102-108.